A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

HIV

Interventions

DRUG

fos-amprenavir calcium, ritonavir

DRUG

abacavir/lamivudine as Epzicom

Trial Locations (1)

University of Miami School of Medicine, Miami